Hayashi, Nobukazu
Ikeda, Masanori
Liu, John
Raymundo, Eliza
Liu, Yingyi
Sasaki, Takuya
Yamasaki, Kenshi
Clinical trials referenced in this document:
Documents that mention this clinical trial
Acne Among Japanese Patients with Atopic Dermatitis Receiving Upadacitinib in the Phase 3 Rising Up Study
https://doi.org/10.1007/s13555-023-00961-9
Safety and Efficacy of Upadacitinib for Atopic Dermatitis in Japan: 2-Year Interim Results from the Phase 3 Rising Up Study
https://doi.org/10.1007/s13555-022-00842-7
Safety and Efficacy of Upadacitinib for Atopic Dermatitis in Japan: Analysis of the 3-Year Phase 3 Rising Up Study
https://doi.org/10.1007/s13555-023-01071-2
Funding for this research was provided by:
AbbVie
Article History
Received: 5 April 2023
Accepted: 5 June 2023
First Online: 25 June 2023